ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v15i1.1845ppharm-1595Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWСезон простуд в разгаре: лечим кашельSeason of Colds and Flu is in Full Swing: Treating Coughhttps://orcid.org/0000-0001-7222-6760ИльинаС. В.IlyinaSvetlana V.

Ильина Светлана Владимировна, доктор медицинских наук, заведующая кафедрой детских инфекционных болезней.

664043, Иркутск, ул. Маршала Конева, д. 90, к. 4, тел.: +7 (3952) 30-04-46

dr_ilina@yahoo.comИркутский государственный медицинский университетРоссияIrkutsk State Medical UniversityRussian Federation2018270220181517579Copyright © Ильина С.В., 20182018Ильина С.В.Ilyina S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1595

Острый кашель является распространенным симптомом и частым поводом обращения за медицинской помощью. Пациенты с острым кашлем нередко прибегают к самолечению с использованием безрецептурных препаратов. Однако эффективность и безопасность таких средств, как правило, не проверяется в строгих условиях клинических исследований. Более того, отмечено большое число побочных эффектов в результате применения у детей подобных препаратов. В статье разбираются вопросы целесообразности медикаментозного лечения нетяжелых случаев острой респираторной инфекции, сопровождаемой кашлем.

Acute cough is a common symptom and a common reason for seeking medical care. Patients with acute cough often practice selfmedication using over-the-counter (OTC) drugs. However, the efficacy and safety of OTC drugs are generally not tested in clinical settings. Moreover, a large number of side effects have been registered in children in response to OTC drugs. The article deals with the issues of the rationality of drug treatment in non-severe cases of acute respiratory infection accompanied by cough.

детикашельбезрецептурные лекарственные средстваострые респираторные инфекцииcoughover-the-counter drugsacute respiratory infectionsНе указанReferencesWHO. The pursuit of responsible use of medicines: sharing and learning from country experiences [Internet]. WHO; 2012. 78 р. [cited 2017 Oct 12]. Available from: http://www.who.int/medicines/publications/responsible_use/en/WHO. The pursuit of responsible use of medicines: sharing and learning from country experiences [Internet]. WHO; 2012. 78 р. [cited 2017 Oct 12]. Available from: http://www.who.int/medicines/publications/responsible_use/en/Worrall G. Acute cough in children. Can Fam Physician. 2011;57(3):315–318.Worrall G. Acute cough in children. Can Fam Physician. 2011;57(3):315–318.Денисова М., Сидорова И. На середине пути. Обзор российского фармацевтического рынка по итогам I полугодия 2013 г. // Ремедиум. Журнал о российском рынке лекарств и медицинской технике. — 2013. — №9 — С. 16–23. [Denisova M, Sidorova I. Half the way. Review of the pharmaceutical market in the first half of 2013. Remedium: zhurnal o rossiiskom rynke lekarstv. 2013;(9):16–23. (In Russ).]Денисова М., Сидорова И. На середине пути. Обзор российского фармацевтического рынка по итогам I полугодия 2013 г. // Ремедиум. Журнал о российском рынке лекарств и медицинской технике. — 2013. — №9 — С. 16–23. [Denisova M, Sidorova I. Half the way. Review of the pharmaceutical market in the first half of 2013. Remedium: zhurnal o rossiiskom rynke lekarstv. 2013;(9):16–23. (In Russ).]Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar — pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321–2324. doi: 10.1056/NEJMp0707400.Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar — pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321–2324. doi: 10.1056/NEJMp0707400.Srinivasan A, Budnitz D, Shehab N, Cohen A. Infant deaths associated with cough and cold medications — two states, 2005. JAMA. 2007;297(8):800–801. doi: 10.1001/jama.297.8.800.Srinivasan A, Budnitz D, Shehab N, Cohen A. Infant deaths associated with cough and cold medications — two states, 2005. JAMA. 2007;297(8):800–801. doi: 10.1001/jama.297.8.800.fda.gov [Internet]. FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age. 2008 [cited 2017 Nov 9]. Available from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051137.htmlfda.gov [Internet]. FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age. 2008 [cited 2017 Nov 9]. Available from: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051137.htmlLokker N, Sanders L, Perrin EM, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–1471. doi: 10.1542/peds.2008-0854.Lokker N, Sanders L, Perrin EM, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–1471. doi: 10.1542/peds.2008-0854.Mallet P, Mourdi N, Dubus JC, et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One. 2011;6(7):e22792. doi: 10.1371/journal.pone.0022792.Mallet P, Mourdi N, Dubus JC, et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One. 2011;6(7):e22792. doi: 10.1371/journal.pone.0022792.ema.europa.eu [Internet]. Revised assessment report. Ambroxol and bromhexine containing medicinal products (EMEA/H/A-31/1397) [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ambroxol_and_bromhexine_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500184106.pdfema.europa.eu [Internet]. Revised assessment report. Ambroxol and bromhexine containing medicinal products (EMEA/H/A-31/1397) [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Ambroxol_and_bromhexine_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500184106.pdfSmith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831. doi: 10.1002/14651858.CD001831.pub5.Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831. doi: 10.1002/14651858.CD001831.pub5.Bennett S, Hoffman N, Monga M. Ephedrine- and guaifenesininduced nephrolithiasis. J Altern Complement Med. 2004;10(6):967–969. doi: 10.1089/acm.2004.10.967.Bennett S, Hoffman N, Monga M. Ephedrine- and guaifenesininduced nephrolithiasis. J Altern Complement Med. 2004;10(6):967–969. doi: 10.1089/acm.2004.10.967.Friedrichsdorf SJ, Nugent AP, Strobl AQ. Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports. J Opioid Manag. 2013;9(2):151–155. doi: 10.5055/jom.2013.0156.Friedrichsdorf SJ, Nugent AP, Strobl AQ. Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports. J Opioid Manag. 2013;9(2):151–155. doi: 10.5055/jom.2013.0156.Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368(9536):704. doi: 10.1016/S0140-6736(06)69255-6.Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368(9536):704. doi: 10.1016/S0140-6736(06)69255-6.European Medicines Agency. Codeine not to be used in children below 12 years for cough and cold [Internet]. London, UK: European Medicines Agency; 2015. [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_cough_or_cold_in_children/Position_provided_by_CMDh/WC500186159.pdfEuropean Medicines Agency. Codeine not to be used in children below 12 years for cough and cold [Internet]. London, UK: European Medicines Agency; 2015. [cited 2017 Nov 9]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_cough_or_cold_in_children/Position_provided_by_CMDh/WC500186159.pdfBenefit/Risk Assessment of Prescription Opioid Antitussive Products for Treatment of Cough in Pediatric Patients [Internet]. Background Document Pediatric Advisory Committee Meeting September 11, 2017 [cited 2017 Nov 9]. Available from: https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM575013.pdfBenefit/Risk Assessment of Prescription Opioid Antitussive Products for Treatment of Cough in Pediatric Patients [Internet]. Background Document Pediatric Advisory Committee Meeting September 11, 2017 [cited 2017 Nov 9]. Available from: https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM575013.pdfDolansky G, Rieder M. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health. 2008;13(2):125–127. doi: 10.1093/pch/13.2.125.Dolansky G, Rieder M. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health. 2008;13(2):125–127. doi: 10.1093/pch/13.2.125.Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Resp Res. 2016;3(1):e000137. doi: 10.1136/bmjresp-2016-000137.Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Resp Res. 2016;3(1):e000137. doi: 10.1136/bmjresp-2016-000137.Bayram E, Karakaya P, Topcu Y, et al. Acute cervical dystonia after the first dose of butamirate citrate. Pediatr Emerg Care. 2013;29(1):80–81. doi: 10.1097/PEC.0b013e31827b5635.Bayram E, Karakaya P, Topcu Y, et al. Acute cervical dystonia after the first dose of butamirate citrate. Pediatr Emerg Care. 2013;29(1):80–81. doi: 10.1097/PEC.0b013e31827b5635.Faruqi S, Wright C, Thompson R, Morice AH. A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers. Br J Clin Pharmacol. 2014;78(6):1272–1280. doi: 10.1111/bcp.12458.Faruqi S, Wright C, Thompson R, Morice AH. A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers. Br J Clin Pharmacol. 2014;78(6):1272–1280. doi: 10.1111/bcp.12458.Основы доказательной медицины. Учебное пособие / Под общей ред. Р.Г. Оганова. — М.: Силицея-Полиграф; 2010. — 136 с. [Osnovy dokazatel’noi meditsiny. Uchebnoe posobie. Ed by R.G. Oganov. Moscow: Silitseya-Poligraf; 2010. 136 p. (In Russ).]Основы доказательной медицины. Учебное пособие / Под общей ред. Р.Г. Оганова. — М.: Силицея-Полиграф; 2010. — 136 с. [Osnovy dokazatel’noi meditsiny. Uchebnoe posobie. Ed by R.G. Oganov. Moscow: Silitseya-Poligraf; 2010. 136 p. (In Russ).]Chalumeau M, Duijvestijn YCM. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013;(5):CD003124. doi: 10.1002/14651858.CD003124.pub4.Chalumeau M, Duijvestijn YCM. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013;(5):CD003124. doi: 10.1002/14651858.CD003124.pub4.Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera Helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;(2011):382789. doi: 10.1155/2011/382789.Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera Helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;(2011):382789. doi: 10.1155/2011/382789.Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev. 2014;(12):CD007094. doi: 10.1002/14651858.CD007094.pub4.Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev. 2014;(12):CD007094. doi: 10.1002/14651858.CD007094.pub4.Mulholland S, Chang AB. Honey and lozenges for children with non-specific cough. Cochrane Database Syst Rev. 2009;(2):CD007523. doi: 10.1002/14651858.CD007523.pub2.Mulholland S, Chang AB. Honey and lozenges for children with non-specific cough. Cochrane Database Syst Rev. 2009;(2):CD007523. doi: 10.1002/14651858.CD007523.pub2.Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Resp Res. 2016;3(1):e000118. doi: 10.1136/bmjresp-2015-000118.Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Resp Res. 2016;3(1):e000118. doi: 10.1136/bmjresp-2015-000118.Abdullah H, Heaney LG, Cosby SL, McGarvey LP. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax. 2014;69(1):46–54. doi: 10.1136/thoraxjnl-2013-203894.Abdullah H, Heaney LG, Cosby SL, McGarvey LP. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax. 2014;69(1):46–54. doi: 10.1136/thoraxjnl-2013-203894.Morice AH, Kantar A, Dicpinigaitis PV, et al. Treating acute cough: wet versus dry — have we got the paradigm wrong? ERJ Open Res. 2015;1(2):00055-2015. doi: 10.1183/23120541.00055-2015.Morice AH, Kantar A, Dicpinigaitis PV, et al. Treating acute cough: wet versus dry — have we got the paradigm wrong? ERJ Open Res. 2015;1(2):00055-2015. doi: 10.1183/23120541.00055-2015.

The authors declare that there are no conflicts of interest present.